Source - SMW
Destiny Pharma founder and chief scientific officer Dr Bill Love will participate in the panel discussion titled 'Novel Ways to Treat and/or Address Infections' at the Cantor Antibiotics Summit.

The Cantor Antibiotics Summit - which is being held at the Omni Berkshire Hotel, 21 East 52nd Street, New York - is hosted by Cantor Fitzgerald and will bring together leading antibiotic companies to discuss novel ways to treat infections, what will drive the uptake of these new products, and important catalysts to look forward to in 2018.

Love will be taking part in the panel which is being held at 12.15 p.m. on 17 Jan.




Related Charts

Destiny Pharma Ord Gbp0.01 (DEST)

0.00p (0.00%)
delayed 16:57PM